Outset Medical, Inc. (NASDAQ:OM) SVP Marc Nash Sells 23,221 Shares

Outset Medical, Inc. (NASDAQ:OM) SVP Marc Nash sold 23,221 shares of the stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $0.80, for a total value of $18,576.80. Following the completion of the sale, the senior vice president now owns 204,968 shares in the company, valued at approximately $163,974.40. The trade was a 10.18 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Marc Nash also recently made the following trade(s):

• On Monday, January 13th, Marc Nash sold 15,011 shares of Outset Medical stock. The stock was sold at an average price of $0.81, for a total transaction of $12,158.91.
• On Tuesday, January 7th, Marc Nash sold 720 shares of Outset Medical stock. The shares were sold at an average price of $1.29, for a total transaction of $928.80.
• On Friday, November 15th, Marc Nash sold 1,375 shares of Outset Medical stock. The stock was sold at an average price of $0.80, for a total transaction of $1,100.00.

Outset Medical Stock Down 3.3 %

NASDAQ:OM traded down $0.03 during mid-day trading on Wednesday, reaching $0.78. The company’s stock had a trading volume of 951,459 shares, compared to its average volume of 2,184,304. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. Outset Medical, Inc. has a 1 year low of $0.44 and a 1 year high of $5.22. The stock has a fifty day moving average of $1.01 and a 200-day moving average of $1.28. The firm has a market capitalization of $40.98 million, a PE ratio of -0.28 and a beta of 2.05.

Institutional Investors Weigh In On Outset Medical

Several hedge funds have recently modified their holdings of the business. Vanguard Personalized Indexing Management LLC purchased a new position in Outset Medical during the second quarter valued at approximately $49,000. Huntington National Bank boosted its position in Outset Medical by 46.2% during the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after acquiring an additional 20,000 shares in the last quarter. National Bank of Canada FI increased its holdings in shares of Outset Medical by 79.2% in the 3rd quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after acquiring an additional 23,164 shares during the period. Squarepoint Ops LLC raised its position in shares of Outset Medical by 74.1% in the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after acquiring an additional 34,187 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Outset Medical during the 2nd quarter worth $259,000.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reiterated a “sector perform” rating and issued a $3.00 price target on shares of Outset Medical in a report on Tuesday, January 7th.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.